Apotex Pty Ltd v Les Laboratoires Servier (No 5)

Link copied
Case Copied 30 min read

FEDERAL COURT OF AUSTRALIA

Apotex Pty Ltd v Les Laboratoires Servier (No 5)

[2015] FCA 334

Citation: Apotex Pty Ltd v Les Laboratoires Servier (No 5) [2015] FCA 334
Parties: APOTEX PTY LTD ACN 096 916 148 v LABORATORIES (AUST) PTY LTD AND ANOTHER AS NAMED IN THE SCHEDULE;  LES LABORATOIRIES SERVIER AND ANOTHER AS NAMED IN THE SCHEDULE v APOTEX PTY LTD ACN 096 916 148 AND ANOTHER AS NAMED IN THE SCHEDULE;  ACTAVIS PTY LIMITED ACN 003 854 626 
File number: NSD 51 of 2012
Judge: RARES J
Date of judgment: 12 March 2015
Catchwords: COSTS – where ultimately successful party lost on nearly all issues litigated in lengthy trial – where issue on which successful party won involved very limited time and evidence – exercise of discretion under s 43 of the Federal Court of Australia Act 1976 (Cth) – power to order costs under s 43(3)(e) regardless of whether party successful in proceedings – where departure from general rule that applicant patentee seeking amendment pay costs of opposing party in litigation and of any third party opponent – offer of compromise under r 25.14(3) of the Federal Court Rules 2011 (Cth) – application of principles in Calderbank v Calderbank [1976] Fam 93
Legislation:

Federal Court of Australia Act 1976 (Cth)
Federal Court Rules 2011 (Cth)
Judiciary Act 1903 (Cth)
Patents Act 1990 (Cth)

Practice of the High Court of Chancery (5th ed (1871) vol 2, p 1239)

Cases cited: Andrews v Australia and New Zealand Banking Group Ltd (2012) 247 CLR 205
Apotex Pty Limited v AstraZeneca AB (No 5) [2013] FCA 560
Apotex Pty Limited v Les Laboratoires Servier (No 3) [2009] FCA 1069
Apotex Pty Ltd v Les Laboratoires Servier [2013] FCA 1426
Apotex Pty Ltd v Les Laboratoires Servier [2015] FCA 104
C Van Der Lely NV v Ruston’s Engineering Co Ltd [1993] RPC 45
Calderbank v Calderbank [1976] Fam 93
Eli Lilly and Co v Pfizer Research and Development Co NV/SA (2003) 59 IPR 234
Elecspess Pty Limited v LED Technologies Pty Limited (2013) 215 FCR 95
Foots v Southern Cross Mine Management Pty Limited (2007) 234 CLR 52
Gambro Pty Limited v Fresenius Medical Care South East Asia Pty Limited [2000] FCA 407
Gray v Richards (No. 2) (2014) 89 ALJR 113
Innovative Agricultural Products Pty Limited v Crawshaw (No 2) [1996] AIPC 91-281
Insight SRC IP Holdings Pty Limited v Australian Council for Education Research Limited (No 2) [2013] FCAFC 73
Kazar v Kargarian (2011) 197 FCR 113
Novozymes A/S v Danisco A/S (No 2) [2013] FCAFC 55 Oshlack v Richmond River Council (1998) 193 CLR 72
Patent Gesellschaft AG v Saudi Livestock Transport and Trading Company (1996) 33 IPR 461
Probiotec Limited v University of Melbourne (2008) 166 FCR 30
Sagacious Legal Pty Limited v Wesfarmers General Insurance Limited [2011] FCAFC 53
Waterside Warkers’ Federation v Stewart (1919) 27 CLR 119
Date of hearing: 12 March 2015
Place: Sydney
Division: GENERAL DIVISION
Category: Catchwords
Number of paragraphs: 62
CaseChat AU logo

Keep reading for free

Create a free CaseChat account to read Apotex Pty Ltd v Les Laboratoires Servier (No 5) and more:

  • Read every judgment in full
  • Ask AI and get answers linked to paragraphs
  • See how each paragraph was cited in later cases
  • Download judgments as PDF or Word
Continue with Google

One click creates your free account or signs you in.

By continuing you agree to the Terms and Privacy Policy.

Details
Case
[2015] FCA 334
Decision Date

CaseChat Overview and Summary

In the case of Apotex Pty Ltd v Les Laboratoires Servier (No 5), Apotex challenged the validity of a patent held by Servier. Apotex was successful on only one issue, the best-method issue, at the conclusion of a lengthy trial in which it had challenged the validity of the patent on numerous grounds. The court was required to determine the appropriate costs order, given that Apotex, though ultimately successful, lost on nearly all issues litigated. The court's discretion under section 43 of the Federal Court of Australia Act 1976 (Cth) and the principles established in Calderbank v Calderbank [1976] Fam 93 were central to the decision. The court considered the nature of the litigation, the timing of the offers of compromise, and the appropriateness of the costs order in light of the unsuccessful issues pursued by Apotex.

The court emphasised the discretionary nature of costs orders and the factors that may influence the exercise of this discretion, such as the unsuccessful issues pursued by the party that ultimately prevailed. It noted that while the general rule is for the successful party to be awarded costs, this is not an absolute rule. The court concluded that the offers of compromise made by Apotex did not affect the appropriate costs order, given the nature and outcome of the litigation. The court exercised its discretion to order costs in a way that reflected the extent to which significant sums of costs had been expended on unsuccessful issues, aligning with the principles of justice and the discretion afforded by section 43 of the Federal Court of Australia Act.

Following its reasoning, the court ordered that Apotex and Actavis pay 60% of Servier's costs of the application to amend and that Apotex pay 66.67% of Servier's costs of the proceedings. This order was intended to reflect the significant resources spent on the unsuccessful issues pursued by Apotex during the litigation. The court's decision was based on a broad evaluative judgment of what justice required in the circumstances of the case, taking into account the unsuccessful issues and the overall conduct of the litigation.

The final orders of the court were as follows: (1) Apotex and Actavis pay 60% of Servier’s costs of the application to amend. (2) Apotex pay 66.67% of Servier’s costs of the proceedings. These orders were intended to ensure that the costs order reflected the reality of the litigation and the unsuccessful issues pursued by Apotex.

Orders

Orders of the court

1. The applicant/cross-respondent and the opponent pay 60% of the respondent/cross-claimant’s costs of the application to amend.

2. The applicant/cross-respondent pay 66.67% of the respondent/cross-claimant’s costs of the proceedings.

Note: Entry of orders is dealt with in Rule 39.32 of the Federal Court Rules 2011.

Background

Background to the litigation

Lee J made similar observations in Innovative Agricultural Products Pty Limited v Crawshaw (No 2) [1996] AIPC 91-281 at p 37,829. I agree with those observations and with what Nicholls LJ, with whom Fox LJ and Sir David Croom-Johnson concurred, said in C Van Der Lely NV v Ruston’s Engineering Co Ltd [1993] RPC 45 at 63 namely that:in appropriate cases, the costs order at the trial should reflect the extent to which significant sums of costs have been thrown away by reason of one party, albeit successful overall, raising and pursuing unsuccessful points.Background The issues both in the trial and the subsequent amendment proceedings are set out in the trial reasons and the amendment reasons. In substance, Apotex won on a discrete, single issue at a trial in which it impugned and litigated the validity of Servier’s patent on many fronts. That winning issue was the best-method issue. In all other substantive respects, Servier’s position was vindicated, on challenges involving the lengthy and time consuming issues of inventive step, obviousness and false suggestion. During the interlocutory stages and in the course of the trial, Apotex abandoned its challenges to the utility of the patent and, after seeing the experts’ joint report, to the sufficiency of the description in the patent. Moreover, Apotex chose to commence the litigation, as its submissions on the costs application explained, to “clear the way”. That is, when it began the proceedings in January 2012, Apotex engaged in a considered attack on the validity of the patent, which it was able to prepare at leisure and on which it struck when it considered that it was ready to pursue the litigation to maximum effect for its commercial benefit. That was its right. However, in exercising that right, Apotex chose the battle grounds on which to assert that the patent was invalid at a time when, commercially, it was ready to launch its generic product. Apotex accepted in the early stages of the proceedings, that, if the patent were valid, the conduct in which it proposed to engage would infringe. That led to the interlocutory injunction preventing Apotex from going to market so as to hold the status quo. That injunction was supported by Servier’s undertaking as to damages on which it now is liable, having regard to the ultimate outcome reflected in the orders made on 26 February 2015 that revoked the patent on the basis of Apotex’ success on the best method issue.The offers of compromise The trial commenced on 8 October 2013. Shortly before that, on 20 September 2013, Apotex made two offers to Servier to compromise the proceedings. The first was made under r 25.14(3), and the second was made as a Calderbank offer. The substance of each offer was the same. Apotex’ solicitors sent the two offers with letters that commenced by asserting that Apotex was in an “extremely strong position”, based on their review of the various affidavits that had been filed on both sides and having regard to the imminent trial. The letters went on to claim that Apotex should win not only on best method point but also on each of the points on which it ultimately failed. The letters and the formal notice of offer to compromise under r 25.01(1) made the following significant proposals as part of the cognate offers:·Apotex’ application for revocation be dismissed;·Servier’s claim for infringement also be dismissed;·the interlocutory injunction be discharged and Servier be released from its undertaking as to damages;·each party bear its own costs; and·Servier grant Apotex a royalty-free, non-exclusive licence under, and for the remainder of the term of, the patent, including any applicable extension in terms substantially as set out in the offers.

Evidence

Evidence Before The Court

Full text does not contain this section.

Decision

Reasons for decision

Accordingly, I am not satisfied that the orders that I have suggested for costs ought be affected by the offers of compromise, on either basis on which Apotex relied.Conclusion For these reasons, I will order that:(1)Apotex and Actavis pay 60% of Servier’s costs of the application to amend.(2)Apotex pay 66.67% of Servier’s costs of the proceedings.

Ratio Decidendi

Legal Principle Established

It is necessary to say something about the Court’s power to order costs before proceeding to deal with the arguments of the parties, some of which appeared to ignore the fact that this power consisted of a judicial discretion. The ordinary principles applied by the Court in considering an award of costs were neatly stated by French CJ, Hayne, Bell, Gageler and Keane JJ in Gray v Richards (No. 2) (2014) 89 ALJR 113 at 113-114 [2] as follows:The disposition of costs is within the general discretion of the Court. Ordinarily, that discretion will be exercised so that costs are awarded to the successful party, but other factors may have a significant claim on the discretion of the Court [Stewart v Atco Controls Pty Ltd (In liq) (No 2) (2014) 252 CLR 331 at 334 [4]]. The disposition which is ultimately to be made in any case where there are competing considerations will reflect a broad evaluative judgment of what justice requires. (emphasis added) Earlier, Gleeson CJ, Gummow, Hayne and Crennan JJ had said in Foots v Southern Cross Mine Management Pty Limited (2007) 234 CLR 52 at 62-63 [25]-[26] with respect to a statutory power similar to that in s 43(1) and (2) of the Federal Court of Australia Act:Before considering those submissions, several general propositions regarding an award of costs should be noted. First, the award is discretionary but generally that discretion is exercised in favour of the successful party; in Queensland, this general understanding is expressed in r 689(1) of the UCPR, which states: “[c]osts of a proceeding, including an application in a proceeding, are in the discretion of the court but follow the event, unless the court considers another order is more appropriate.” Further, although capable of estimation, the actual monetary value of an award of costs cannot be ascertained until those costs are taxed or otherwise assessed.In Oshlack v Richmond River Council [(1998) 193 CLR 72], this Court emphasised the breadth of the power exercised in making costs orders. There the trial judge had made no order as to costs despite the Council's success, and this decision was affirmed on appeal to this Court. Gaudron and Gummow JJ rejected a submission that there was an automatic rule that costs always follow the event [(1998) 193 CLR 72 at 88 [40]-[41] (footnote omitted)]:“There is no absolute rule with respect to the exercise of the power conferred by a provision such as s 69 of the [Land and Environment] Court Act [1979 (NSW)] that, in the absence of disentitling conduct, a successful party is to be compensated by the unsuccessful party. Nor is there any rule that there is no jurisdiction to order a successful party to bear the costs of the unsuccessful party.If regard be had to the myriad circumstances presenting themselves in the institution and conduct of litigation, and to the varied nature of litigation, particularly in the equity jurisdiction, it will be seen that there is nothing remarkable in the above propositions.” (emphasis added)